| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41598-017-17869-Y |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/s41598-017-17869-y |
| P8608 | Fatcat ID | release_re3xeofogjdippiuj7han5xiwq |
| P932 | PMC publication ID | 5727478 |
| P698 | PubMed publication ID | 29235530 |
| P50 | author | Stephen C Balmert | Q83347455 |
| P2093 | author name string | Steven R Little | |
| Abhinav P Acharya | |||
| Michelle L Ratay | |||
| Thiagarajan Meyyappan | |||
| Ashlee C Greene | |||
| P2860 | cites work | Lifitegrast, a Novel Integrin Antagonist for Treatment of Dry Eye Disease | Q26774853 |
| Design of a superior cytokine antagonist for topical ophthalmic use | Q27676526 | ||
| Regulatory T cells: how do they suppress immune responses? | Q37593768 | ||
| Impact of dry eye disease and treatment on quality of life | Q37751734 | ||
| Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting | Q38151227 | ||
| Clinical staining of the ocular surface: mechanisms and interpretations. | Q38280774 | ||
| Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease. | Q38787674 | ||
| Desiccating stress-induced disruption of ocular surface immune tolerance drives dry eye disease. | Q38810021 | ||
| Positive Charge of "Sticky" Peptides and Proteins Impedes Release From Negatively Charged PLGA Matrices. | Q38994544 | ||
| Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop | Q41448579 | ||
| Evaluation of topical cyclosporine for the treatment of dry eye disease | Q44443222 | ||
| Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. | Q45879987 | ||
| Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg. | Q45993589 | ||
| Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye. | Q46460231 | ||
| In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation | Q46460388 | ||
| Tear production and ocular surface changes in experimental dry eye after elimination of desiccating stress. | Q53410341 | ||
| Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. | Q53883439 | ||
| Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. | Q54185769 | ||
| Dry Eye Disease | Q61759579 | ||
| Dry Eye–Induced Conjunctival Epithelial Squamous Metaplasia Is Modulated by Interferon-γ | Q61851323 | ||
| Desiccating Stress Induces T Cell-Mediated Sjogren's Syndrome-Like Lacrimal Keratoconjunctivitis | Q61851332 | ||
| Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation | Q70562670 | ||
| Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine | Q77729873 | ||
| GITR ligation blocks allograft protection by induced CD25+CD4+ regulatory T cells without enhancing effector T-cell function | Q80054509 | ||
| Topical TSG-6 Administration Protects the Ocular Surface in Two Mouse Models of Inflammation-Related Dry Eye | Q85732408 | ||
| Therapeutic effects of topical doxycycline in a benzalkonium chloride-induced mouse dry eye model | Q87659378 | ||
| Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target | Q28750209 | ||
| How regulatory T cells work | Q29614262 | ||
| Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. | Q30813799 | ||
| Betulin is a potent anti-tumor agent that is enhanced by cholesterol | Q30862438 | ||
| Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation | Q33573450 | ||
| The diagnosis and management of dry eye: a twenty-five-year review | Q34048201 | ||
| Characterization of effector T cells in dry eye disease | Q34065949 | ||
| The ocular surface and tear film and their dysfunction in dry eye disease | Q34093781 | ||
| Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
| Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy | Q34116065 | ||
| The economic burden of dry eye disease in the United States: a decision tree analysis | Q34147677 | ||
| Regulatory T cells and Foxp3 | Q34177949 | ||
| Dry eye disease: the scale of the problem | Q34391914 | ||
| The pathology of dry eye. | Q34391929 | ||
| A mouse dry eye model induced by topical administration of benzalkonium chloride. | Q34538059 | ||
| Chemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye disease | Q35040958 | ||
| Tears in health and disease | Q35590404 | ||
| Mesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye. | Q35591394 | ||
| The living eye "disarms" uncommitted autoreactive T cells by converting them to Foxp3(+) regulatory cells following local antigen recognition | Q35740108 | ||
| The role of the lacrimal functional unit in the pathophysiology of dry eye. | Q35755146 | ||
| Efficacy of topical blockade of interleukin-1 in experimental dry eye disease | Q36044544 | ||
| Corticosteroid-induced glaucoma: a review of the literature | Q36118249 | ||
| Tolerogenic dendritic cells and their applications in transplantation | Q36302853 | ||
| Aqueous Tear Deficiency Increases Conjunctival Interferon-γ (IFN-γ) Expression and Goblet Cell Loss | Q36345503 | ||
| An eye's view of T regulatory cells | Q36694747 | ||
| Natural regulatory T cells: mechanisms of suppression | Q36719995 | ||
| Dry eye disease: an immune-mediated ocular surface disorder | Q36916372 | ||
| Controlled release formulations of IL-2, TGF-β1 and rapamycin for the induction of regulatory T cells. | Q36998551 | ||
| Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression | Q37071969 | ||
| Peripherally induced tregs - role in immune homeostasis and autoimmunity | Q37076945 | ||
| Advances in understanding and managing dry eye disease | Q37206550 | ||
| Human regulatory T cells: role in autoimmune disease and therapeutic opportunities | Q37211296 | ||
| Prevention of inflammation-mediated bone loss in murine and canine periodontal disease via recruitment of regulatory lymphocytes | Q37319692 | ||
| T helper cytokines in dry eye disease | Q37374838 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microsphere | Q1759020 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 17527 | |
| P577 | publication date | 2017-12-13 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | TRI Microspheres prevent key signs of dry eye disease in a murine, inflammatory model | |
| P478 | volume | 7 |
Search more.